Last reviewed · How we verify

NCT07530653: PERMIT-LATAM

Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries.

Not yet recruiting Last updated 15 April 2026
What this trial tests

trial testing Crystalloid below 1000 mL. in Trauma and Emergency Care in 716 participants. Not yet recruiting.

Timeline
1 October 2026
Primary endpoint
30 September 2028
30 November 2028

Quick facts

Lead sponsorHospital Departamental de Villavicencio
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment716
Start date1 October 2026
Primary completion30 September 2028
Estimated completion30 November 2028
Sites1 location across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Departamental de Villavicencio

Who can join

Adults 18 to 100, any sex, with Trauma and Emergency Care or Shock,Hemorrhagic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will provide information on the quality of care in hemorrhagic shock of severe injuries in a limited resource facility of Latin America, the strategies of fluid resuscitation, and outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospital Departamental de Villavicencio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07530653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing